Thanks. I'm happy to discuss medical isotopes.
The first thing I think we need to recognize is that there are only two ways of producing medical isotopes, through cyclotron technology like that amazing company called TRIUMF, out of British Columbia, which we have a very close partnership with. There are cyclotrons and reactors at universities and other institutions in Canada.
Not to get into physics 101, but the types of isotopes you can make in a nuclear reactor, like cobalt or lutetium, you can't make in a cyclotron. The types of isotopes you can make in a cyclotron, you can't make in a nuclear reactor. We need both, and that's why we have the Canadian Nuclear Isotope Council.
If you think about energy, an isotope is a modern form of energy that is used in modern health care across the world. As developing countries continue to move more people into the middle class and give people more access to cancer diagnostics and treatment, with more people fighting COVID-19 who need sterilized medical equipment, the demand for medical isotopes is going to increase. Canada is uniquely positioned to provide those isotopes.
On the reactor side, through our power reactors like the ones we operate at Bruce Power but also through our cyclotrons at areas like the University of British Columbia and TRIUMF Innovations—and they're both needed—it is a multi-billion dollar opportunity.
It will mean that we will have clinical trials come to Canada, so Canadians can have access to some of the best cancer treatments.
I happen to chair an organization in Ontario called the Pediatric Oncology Group of Ontario, where we help families and kids with cancer. What I want as a parent and as a Canadian is to see everybody in the world have access to those kinds of cancer treatments, but I want Canada to be the world leader in medical isotopes in cancer treatment, and we can do that through our isotope advantage.